These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21549480)

  • 1. Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.
    Herford AS; Lu M; Buxton AN; Kim J; Henkin J; Boyne PJ; Caruso JM; Rungcharassaeng K; Hong J
    J Oral Maxillofac Surg; 2012 Mar; 70(3):703-16. PubMed ID: 21549480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.
    Lu SX; Fiorini T; Lee J; Prasad HS; Buxton AN; Bisch FC; Dixon DR; Susin C; Wikesjö UM
    J Clin Periodontol; 2013 Jul; 40(7):688-97. PubMed ID: 23627347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
    Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
    J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
    Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
    Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
    Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs.
    Lee JS; Wikesjö UM; Jung UW; Choi SH; Pippig S; Siedler M; Kim CK
    J Clin Periodontol; 2010 Apr; 37(4):382-9. PubMed ID: 20447262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons.
    Miranda DA; Blumenthal NM; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2005 Feb; 76(2):210-20. PubMed ID: 15974844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects.
    Barboza EP; Caúla AL; Caúla Fde O; de Souza RO; Geolás Neto L; Sorensen RG; Li XJ; Wikesjö UM
    J Periodontol; 2004 May; 75(5):702-8. PubMed ID: 15212353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
    Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot experimental lateral ridge augmentation study using bone morphogenetic protein 2 in dogs.
    Yamashita M; Nevins M; Jones AA; Schoolfield J; Cochran DL
    Int J Periodontics Restorative Dent; 2010 Oct; 30(5):457-69. PubMed ID: 20814599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
    Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
    J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2.
    Hanisch O; Tatakis DN; Boskovic MM; Rohrer MD; Wikesjö UM
    Int J Oral Maxillofac Implants; 1997; 12(5):604-10. PubMed ID: 9337020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
    Boyne PJ
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
    Blumenthal NM; Koh-Kunst G; Alves ME; Miranda D; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2002 Dec; 73(12):1494-506. PubMed ID: 12546100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates.
    Hanisch O; Tatakis DN; Rohrer MD; Wöhrle PS; Wozney JM; Wikesjö UM
    Int J Oral Maxillofac Implants; 1997; 12(6):785-92. PubMed ID: 9425759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier.
    Wikesjö UM; Qahash M; Thomson RC; Cook AD; Rohrer MD; Wozney JM; Hardwick WR
    Clin Implant Dent Relat Res; 2003; 5(2):112-23. PubMed ID: 14536046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.